Eleven Vibrio vulnificus (lactose-positive vibrio) strains were less susceptible to the bactericidal activity of normal human serum or serum treated with magnesium-ethyleneglycol-bis (,f-aaminoethyl ether) Complement-mediated bactericidal activity is considered a primary defense against gram-negative bacteremia, and conversely, bacteria isolated from bloodstream infections are frequently serum resistant (9). The reported deficiency of cirrhotic sera in bactericidal activity against serum-sensitive Escherichia coli (3) prompted us to explore whether differences between V. parahaemolyticus and V. vulnificus in their susceptibilities to serum might explain their different pathogenicities. We examined the susceptibilities of 6 V. parahaemolyticus and 11 V. vulni- V. parahaemolyticus strains examined were M5242-1, 33C10, MY001, WP1, and MY74-001, all Kanagawa-positive human fecal isolates, and M5253J1, a Kanagawa-negative seafood isolate. Strains M5242-1 and M5253J1 were supplied by the Centers for Disease Control, Atlanta, Ga., strain 33C10 was supplied by the Food and Drug Administration, Washington, D.C., and strains MY001, WP1, and MY74-001 were supplied by Yoshifumi Takeda, Osaka, Japan. V. vulnificus strains were blood isolates A3308, A8694, C7184, C8806, E6184, E6185, soft-tissue isolates A1402, B3547, C2756, D9889, and oyster isolate D4473. All strains were originally supplied by Dannie Hollis of the Centers for Disease Control. Some strains were transmitted to us by James D. Oliver ofthe University of North Carolina, Charlotte, N.C. Bacteria were stored on cystine tryptic agar slants. Bacteria were streaked for purity, inoculated into veal infusion broth with NaCl added to 2%, and incubated at 37°C for 4 to 5 h in a shake culture.
Eleven Vibrio vulnificus (lactose-positive vibrio) strains were less susceptible to the bactericidal activity of normal human serum or serum treated with magnesium-ethyleneglycol-bis (,f-aaminoethyl ether) -N, N'-tetraacetic acid than were six Vibrio parahaemolyticus strains.
Vibrio parahaemolyticus and Vibrio vulnificus (this nomenclature for V. vulnificus has been agreed upon, as reported recently by Baumann[l]) (lactose-positive vibrio, Beneckea vulnifica) are biochemically and morphologically similar bacteria which cause quite different diseases when they infect humans. The two bacteria were not differentiated in some early reports, but it now appears that V. parahaemolyticus usually causes gastrointestinal infection, and rarely wound infection, but it almost never causes bacteremia. On the other hand, about half of the reported cases of V. vulnificus disease are wound infections, and the remainder are bacteremias, of which about three-quarters occur in individuals with preexisting hepatic disease (2). The association of V. vulnificus, but not V. parahaemolyticus, with systemic infection makes it likely that the two bacteria differ in their susceptibilities to host defense mechanisms.
Complement-mediated bactericidal activity is considered a primary defense against gram-negative bacteremia, and conversely, bacteria isolated from bloodstream infections are frequently serum resistant (9) . The reported deficiency of cirrhotic sera in bactericidal activity against serum-sensitive Escherichia coli (3) prompted us to explore whether differences between V. parahaemolyticus and V. vulnificus in their susceptibilities to serum might explain their different pathogenicities. We examined the susceptibilities of 6 V. parahaemolyticus and 11 V. vulni- V. parahaemolyticus strains examined were M5242-1, 33C10, MY001, WP1, and MY74-001, all Kanagawa-positive human fecal isolates, and M5253J1, a Kanagawa-negative seafood isolate. Strains M5242-1 and M5253J1 were supplied by the Centers for Disease Control, Atlanta, Ga., strain 33C10 was supplied by the Food and Drug Administration, Washington, D.C., and strains MY001, WP1, and MY74-001 were supplied by Yoshifumi Takeda, Osaka, Japan. V. vulnificus strains were blood isolates A3308, A8694, C7184, C8806, E6184, E6185, soft-tissue isolates A1402, B3547, C2756, D9889, and oyster isolate D4473. All strains were originally supplied by Dannie Hollis of the Centers for Disease Control. Some strains were transmitted to us by James D. Oliver ofthe University of North Carolina, Charlotte, N.C. Bacteria were stored on cystine tryptic agar slants. Bacteria were streaked for purity, inoculated into veal infusion broth with NaCl added to 2%, and incubated at 37°C for 4 to 5 h in a shake culture.
Blood was obtained by venipuncture of three or more healthy individuals without history of vibrio infection or contact. Pooled sera were separated and used immediately or stored in aliquots at -70°C. Fresh or freshly thawed serum was used unaltered and heated at 56°C for 30 min and/or made approximately 10 mM in Mg-EGTA by the addition of a stock solution of 100 mM Mg-EGTA prepared by the method of Fine (4) . Serum-sensitive strain A1402 was used as a control for each experiment.
The bacterial inoculum (approxiimately 1 x 107 colony-forming units) in 0.35 ml of phosphate-buffered saline and 0.65 ml of treated or untreated serum were mixed in a plastic tube; 0.1 ml of the mixture was withdrawn for an initial viable count, and the remainder was incubated at 37°C for 30 or 60 min. Tenfold dilutions were made in phosphate-buffered saline, inoculated on duplicate plates of brain heart infusion agar containing 2% NaCl, incubated overnight at 37°C, and read. More than 1 logio reduction in colony-forming units was consid- The V. parahaemolyticus strains were uniformly serum sensitive (Fig. 1) , whereas V. vulnificus strains varied in their sensitivities. The five V. vulnificus strains isolated originally from blood were somewhat less sensitive than the five soft-tissue isolates or the single environmental isolate, but sensitive and resistant strains were found in each group (Fig. 2) .
Bactericidal tests were run in parallel with normal serum and Mg-EGTA-treated serum on the six V. parahaemolyticus and six serum-sensitive V. vulnificus strains. Bactericidal activity was determined at 30 and 60 min with the Mg-EGTA-treated serum because of the delayed activation of the altemative pathway observed with other bacterial genera (5). Bactericidal ac- tivity in Mg-EGTA-treated serum was more rapid and more complete against V. parahaemolyticus strains than against V. vulnificus strains. Bactericidal activity is shown in Fig. 3 for one strain of each bacterium, but each strain was typical of its group.
These results suggest that some strains of V.
vulnificus are not susceptible to the bactericidal action of normal serum by either pathway of complement activation, whereas the remaining strains activate the classical pathway well and the alternative pathway less effectively. These findings are of interest in light of the observations of Fierer and Finley on sera from cirrhotic individuals (3). Cirrhotic sera had an intact altemative pathway ofcomplement-mediated bactericidal activity against E. coli but often had suboptimal classical pathway activity. Thus, if cirrhotic individuals are dependent primarily on altemative pathway activation for bactericidal activity against gram-negative bacteria, they might be more vulnerable to systemic invasion by bacteria, such as V. vulnificus which are less efficient activators of the altemative pathway. These results support the concept, previously advanced from animal studies by Poole and Oliver (8) the increasing serum susceptibilities of the strains to parallel the increase in 50% lethal doses observed in their mouse studies. Murine serum has been reported to lack bactericidal activity (6), although murine altemative pathway activity has been demonstrated recently in a hemolytic system (7) . LITERATURE CITED
